HN Summary • Canada has invested heavily in biomanufacturing infrastructure, but many facilities remain underused. • More funding, skilled workers and support for biotech companies are needed to turn research into commercial-scale manufacturing.
HN Summary • Canada has invested heavily in biomanufacturing infrastructure, but many facilities remain underused.
• More funding, skilled workers and support for biotech companies are needed to turn research into commercial-scale manufacturing.
• Canada could become more globally competitive by improving incentives, streamlining clinical trials and keeping manufacturing at home.
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
HN Summary • Canada has invested heavily in biomanufacturing infrastructure, but many facilities remain underused. • More funding, skilled workers and support for biotech companies are needed to turn research into commercial-scale manufacturing. • Canada could become more globally competitive by improving incentives, streamlining clinical trials and keeping manufacturing at home.
Open the app view to save this story, compare related coverage, and continue from the same source.